Bonnet N, Benhamou CL, Malaval L, Goncalves C, Vico L, Eder V, Pichon C, Courteix D (2008) Low dose beta-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions
Researchers are finding more indications every day for patients to take these weight loss medications
We have selected representative candidates based on the following criteria: (1) Clinical relevance: BsADCs that have entered clinical trials and generated reported data (e.g., ZW49, MEDI4276, BL-B01D1, JSKN016)
Cell Neurosci
By month three, most people on therapeutic doses have lost 5 to 10 percent of their starting body weight
The most common side effects include nausea, vomiting, and injection site reactions